Potential plausible role of Wharton's jelly mesenchymal stem cells for diabetic bone regeneration.

ABSTRACT

This letter addresses the review titled "Wharton's jelly mesenchymal stem cells Future regenerative medicine for clinical applications in mitigation of radiation injury". The review highlights the regenerative potential of Wharton's jelly mesenchymal stem cells (WJ-MSCs) and describes why WJ-MSCs will become one of the most probable stem cells for future regenerative medicine. The potential plausible role of WJ-MSCs for diabetic bone regeneration should be noticeable, which will provide a new strategy for improving bone regeneration under diabetic conditions.